NGVT Quote, Financials, Valuation and Earnings

The Chemours has a net margin of 7.22% compared to Ingevity's net margin of -0.29%. Ingevity's return on equity of -118.15% beat The Chemours's return on equity of 4.67%.

Ingevity has a consensus price target of $51.75, signalling upside risk potential of 24.85%. On the other hand The Chemours has an analysts' consensus of $14.75 which suggests that it could grow by 46.48%. Given that The Chemours has higher upside potential than Ingevity, analysts believe The Chemours is more attractive than Ingevity.

Ingevity has a beta of 1.386, which suggesting that the stock is 38.613% more volatile than S&P 500. In comparison The Chemours has a beta of 1.642, suggesting its more volatile than the S&P 500 by 64.18%.

Ingevity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Chemours offers a yield of 8.32% to investors and pays a quarterly dividend of $0.09 per share. Ingevity pays -- of its earnings as a dividend. The Chemours pays out 172.09% of its earnings as a dividend.

Ingevity quarterly revenues are $284M, which are smaller than The Chemours quarterly revenues of $1.4B. Ingevity's net income of $20.5M is higher than The Chemours's net income of -$4M. Notably, Ingevity's price-to-earnings ratio is -- while The Chemours's PE ratio is 53.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ingevity is 1.12x versus 0.26x for The Chemours. Usually stocks with elevated PS ratios are considered overvalued.

Innospec has a net margin of 7.22% compared to Ingevity's net margin of 7.44%. Ingevity's return on equity of -118.15% beat Innospec's return on equity of 2.21%.

Ingevity has a consensus price target of $51.75, signalling upside risk potential of 24.85%. On the other hand Innospec has an analysts' consensus of $115.00 which suggests that it could grow by 33.47%. Given that Innospec has higher upside potential than Ingevity, analysts believe Innospec is more attractive than Ingevity.

Ingevity has a beta of 1.386, which suggesting that the stock is 38.613% more volatile than S&P 500. In comparison Innospec has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.249%.

Ingevity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Innospec offers a yield of 1.89% to investors and pays a quarterly dividend of $0.84 per share. Ingevity pays -- of its earnings as a dividend. Innospec pays out 108.99% of its earnings as a dividend.

Ingevity quarterly revenues are $284M, which are smaller than Innospec quarterly revenues of $440.8M. Ingevity's net income of $20.5M is lower than Innospec's net income of $32.8M. Notably, Ingevity's price-to-earnings ratio is -- while Innospec's PE ratio is 81.28x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ingevity is 1.12x versus 1.21x for Innospec. Usually stocks with elevated PS ratios are considered overvalued.

ArcelorMittal SA has a net margin of 7.22% compared to Ingevity's net margin of 5.44%. Ingevity's return on equity of -118.15% beat ArcelorMittal SA's return on equity of 2.23%.

Ingevity has a consensus price target of $51.75, signalling upside risk potential of 24.85%. On the other hand ArcelorMittal SA has an analysts' consensus of $32.22 which suggests that it could grow by 6.23%. Given that Ingevity has higher upside potential than ArcelorMittal SA, analysts believe Ingevity is more attractive than ArcelorMittal SA.

Ingevity has a beta of 1.386, which suggesting that the stock is 38.613% more volatile than S&P 500. In comparison ArcelorMittal SA has a beta of 1.651, suggesting its more volatile than the S&P 500 by 65.075%.

Ingevity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ArcelorMittal SA offers a yield of 1.73% to investors and pays a quarterly dividend of $0.28 per share. Ingevity pays -- of its earnings as a dividend. ArcelorMittal SA pays out 29.35% of its earnings as a dividend. ArcelorMittal SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ingevity quarterly revenues are $284M, which are smaller than ArcelorMittal SA quarterly revenues of $14.8B. Ingevity's net income of $20.5M is lower than ArcelorMittal SA's net income of $805M. Notably, Ingevity's price-to-earnings ratio is -- while ArcelorMittal SA's PE ratio is 19.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ingevity is 1.12x versus 0.39x for ArcelorMittal SA. Usually stocks with elevated PS ratios are considered overvalued.

Olympic Steel has a net margin of 7.22% compared to Ingevity's net margin of 0.51%. Ingevity's return on equity of -118.15% beat Olympic Steel's return on equity of 2.95%.

Ingevity has a consensus price target of $51.75, signalling upside risk potential of 24.85%. On the other hand Olympic Steel has an analysts' consensus of $41.00 which suggests that it could grow by 29.95%. Given that Olympic Steel has higher upside potential than Ingevity, analysts believe Olympic Steel is more attractive than Ingevity.

Ingevity has a beta of 1.386, which suggesting that the stock is 38.613% more volatile than S&P 500. In comparison Olympic Steel has a beta of 1.658, suggesting its more volatile than the S&P 500 by 65.776%.

Ingevity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Olympic Steel offers a yield of 1.97% to investors and pays a quarterly dividend of $0.16 per share. Ingevity pays -- of its earnings as a dividend. Olympic Steel pays out 29.07% of its earnings as a dividend. Olympic Steel's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ingevity quarterly revenues are $284M, which are smaller than Olympic Steel quarterly revenues of $492.9M. Ingevity's net income of $20.5M is higher than Olympic Steel's net income of $2.5M. Notably, Ingevity's price-to-earnings ratio is -- while Olympic Steel's PE ratio is 22.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ingevity is 1.12x versus 0.19x for Olympic Steel. Usually stocks with elevated PS ratios are considered overvalued.